Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

813 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatic arterial infusion chemotherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: exploring the influence of prior transarterial chemoembolization and additional transarterial chemoembolization on survival outcomes.
Hien PN, Chun HJ, Oh JS, Kim SH, Choi BG. Hien PN, et al. Among authors: chun hj. J Gastrointest Oncol. 2024 Apr 30;15(2):721-729. doi: 10.21037/jgo-23-1006. Epub 2024 Apr 26. J Gastrointest Oncol. 2024. PMID: 38756625 Free PMC article.
Efficacy and safety of transarterial chemoembolization alone compared to its combination with anlotinib among patients with intermediate or advanced stage hepatocellular carcinoma: a phase II randomized controlled trial.
Zhang D, Zhang Z, Luo J, Zheng J, Mao X, Tsilimigras DI, Chun HJ, Zeng H. Zhang D, et al. Among authors: chun hj. J Gastrointest Oncol. 2024 Aug 31;15(4):1627-1635. doi: 10.21037/jgo-24-497. Epub 2024 Aug 28. J Gastrointest Oncol. 2024. PMID: 39279973 Free PMC article.
Comparative Analysis of Atezolizumab Plus Bevacizumab and Hepatic Artery Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter, Propensity Score Study.
Kim JH, Nam HC, Kim CW, Cho HS, Yoo JS, Han JW, Jang JW, Choi JY, Yoon SK, Yang H, Bae SH, Kim S, Oh JS, Chun HJ, Jeon CH, Ahn J, Sung PS. Kim JH, et al. Among authors: chun hj. Cancers (Basel). 2023 Aug 24;15(17):4233. doi: 10.3390/cancers15174233. Cancers (Basel). 2023. PMID: 37686509 Free PMC article.
Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study.
Yoo JS, Kim JH, Cho HS, Han JW, Jang JW, Choi JY, Yoon SK, Kim S, Oh JS, Chun HJ, Sung PS. Yoo JS, et al. Among authors: chun hj. Abdom Radiol (NY). 2024 Sep;49(9):3127-3135. doi: 10.1007/s00261-024-04308-6. Epub 2024 Apr 28. Abdom Radiol (NY). 2024. PMID: 38678485
813 results